Develops advanced blockchain technology specifically for the healthcare industry. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
The gap is $1K. In times of high interest rates, a gap like that can squeeze a company.
The market pays 107.6× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 17% — still a thick cushion, though costs have been eating into it lately.
The stock sits at $0.0000. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 108 times its annual profit. Even a small disappointment could hit the price hard.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.